JPH0377900A - 血漿因子、その精製方法およびそれを有効成分として含有する血栓溶解剤 - Google Patents

血漿因子、その精製方法およびそれを有効成分として含有する血栓溶解剤

Info

Publication number
JPH0377900A
JPH0377900A JP1213912A JP21391289A JPH0377900A JP H0377900 A JPH0377900 A JP H0377900A JP 1213912 A JP1213912 A JP 1213912A JP 21391289 A JP21391289 A JP 21391289A JP H0377900 A JPH0377900 A JP H0377900A
Authority
JP
Japan
Prior art keywords
plasma
heparin
sepharose
molecular weight
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1213912A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0577680B2 (enExample
Inventor
Osamu Matsuo
理 松尾
Kiyotaka Okada
清孝 岡田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kindai University
Original Assignee
Kindai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kindai University filed Critical Kindai University
Priority to JP1213912A priority Critical patent/JPH0377900A/ja
Publication of JPH0377900A publication Critical patent/JPH0377900A/ja
Publication of JPH0577680B2 publication Critical patent/JPH0577680B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP1213912A 1989-08-19 1989-08-19 血漿因子、その精製方法およびそれを有効成分として含有する血栓溶解剤 Granted JPH0377900A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1213912A JPH0377900A (ja) 1989-08-19 1989-08-19 血漿因子、その精製方法およびそれを有効成分として含有する血栓溶解剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1213912A JPH0377900A (ja) 1989-08-19 1989-08-19 血漿因子、その精製方法およびそれを有効成分として含有する血栓溶解剤

Publications (2)

Publication Number Publication Date
JPH0377900A true JPH0377900A (ja) 1991-04-03
JPH0577680B2 JPH0577680B2 (enExample) 1993-10-27

Family

ID=16647092

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1213912A Granted JPH0377900A (ja) 1989-08-19 1989-08-19 血漿因子、その精製方法およびそれを有効成分として含有する血栓溶解剤

Country Status (1)

Country Link
JP (1) JPH0377900A (enExample)

Also Published As

Publication number Publication date
JPH0577680B2 (enExample) 1993-10-27

Similar Documents

Publication Publication Date Title
Thorsen et al. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma: evidence for a rapid plasminogen activator inhibitor
Lijnen et al. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein.
Meijers et al. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor
Salonen et al. Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin.
US5336610A (en) Method for purification of the zymogen of protein C or the heavy chain thereof using monoclonal antibody HPC-4
JP2001086984A (ja) アフィニティークロマトグラフィーによって血液凝固第vii因子を活性化するプロテアーゼ、そのプロ酵素または両タンパク質の混合物を純粋形態で調製する方法
CA2006684C (en) Monoclonal antibody against protein c
Holvoet et al. Characterization of functional domains in human tissue‐type plasminogen activator with the use of monoclonal antibodies
CN104789544A (zh) 重组pai-1抑制剂、包含其的组合物及其用于治疗和检测用途
CN113416724B (zh) 一种组织型纤溶酶原激活剂的重组蛋白及其应用
EP0245100B1 (en) Purification of single-chain and double-chain tissue plasminogen activator
Ostapchenko et al. Enzyme electrophoresis method in analysis of active components of haemostasis system
Morris et al. Role of the lysine binding regions in the kinetic properties of human plasmin
CA1331158C (en) Method, device and kit for measurement of tissue plasminogen activator activity
de Serrano et al. Influence of various structural domains of fibrinogen and fibrin on the potentiation of plasminogen activation by recombinant tissue plasminogen activator
Marcotte et al. Characterization of a metalloprotease which cleaves with high site-specificity the Glu (143)-Leu (144) bond of urokinase
JPS63119675A (ja) 変形組織プラスミン活性化剤
JPH0377900A (ja) 血漿因子、その精製方法およびそれを有効成分として含有する血栓溶解剤
EP3812772B1 (en) Method for diagnosing fibrinolytic insufficiency related to neutrophil extracellular traps
JP2003286300A (ja) 血液凝固第vii因子活性化プロテアーゼに対する抑制性モノクローナル抗体
US5422090A (en) Human PAI-2
KR100583537B1 (ko) 활성화된 응고 인자 vii에 특이적인 모노클로날 항체 및 이의 용도
HU203257B (en) Process for producing monoclonal antiurokinase antibodies and for cleaning and testing urokinase
EP0487660B1 (en) Treatment of thrombotic events
DE3782274T2 (de) Selektiver immunoassay fuer pro-urokinase und urokinase.